Table 1.
Systematic review of pregnant women's willingness toward the SARS-CoV-2 vaccination and associated factors.
| 1st author | Year | Study location | Study design | Sample size | Risk factors (OR, 95% CI) | NOS |
|---|---|---|---|---|---|---|
| Goncu Ayhan et al.16 | 2021 | Ankara, Turkey | Cross-sectional | 300 | Sufficient information about the SARS-CoV-2 vaccine (2.07, 1.22–3.51) | 7 |
| Battarbee et al.17 | 2021 | U.S. | Cross-sectional multicenter | 915 | Higher school education (2.40, 1.30–4.70) Received influenza vaccine last year (2.60, 1.90–3.60) |
8 |
| Levy et al.18 | 2021 | New York | Survey study | 653 | Sufficient information about the SARS-CoV-2 vaccine (30.95, 9.55–100.33) | 7 |
| Geoghegan et al.19 | 2021 | Dublin, Ireland | Online survey | 300 | >35 years old (1.36, 0.80–2.32) Higher school education (1.78, 1.09–2.92) |
6 |
| Hailemariam et al.20 | 2021 | Southwest Ethiopia | Cross-sectional | 412 | >35 years old (6.73, 3.84–11.79) Higher school education (5.87, 3.14–10.97) High perception of SARS-CoV-2 vaccine (4.35, 2.73–6.95) |
7 |
| Mose et al.21 | 2021 | Southwest Ethiopia | Cross-sectional | 396 | >35 years old (2.55, 1.06–6.08) Higher school education (3.28, 1.92–5.59) Sufficient information about the SARS-CoV-2 vaccine (3.24, 1.78–5.89) Good practice (9.15, 8.73–12.19) |
7 |
| Nguyen et al.22 | 2021 | Vietnam | Cross-sectional | 651 | Higher school education (1.98, 1.24–3.14) High perception of SARS-COV-2 vaccine (2.71, 1.93–3.82) |
7 |
| Skjefte et al.23 | 2021 | U.S., U.K., India, Brazil, Russia, Spain, Argentina, Colombia, Mexico, Peru, South Africa, Italy, Chile, Philippines, Australia and New Zealand | Cross-sectional | 5,294 | Higher school education (1.31, 1.12–1.54) Received influenza vaccine last year (3.29, 2.91–3.72) |
8 |
| Stuckelberger et al.24 | 2021 | Switzerland | Cross-sectional | 1,551 | >35 years old (2.00, 1.30–3.00) Higher school education (1.70, 1.30–2.20) Received influenza vaccine last year (3.60, 2.80–4.70) Third trimester (1.40,1.00–2.00) |
7 |
| Sutton et al.25 | 2021 | U.S. | Online survey | 1,012 | Received influenza vaccine last year (2.25, 1.66–3.05) | 7 |
| Tao et al.26 | 2021 | China | Cross-sectional | 1,392 | Higher school education (2.85, 1.45–5.59) Sufficient information about the SARS-CoV-2 vaccine (1.05, 1.01–1.10) Third trimester (1.49,1.03–2.16) |
7 |
| Wang et al.27 | 2021 | China | Cross-sectional | 2,568 | Sufficient information about the SARS-CoV-2 vaccine (2.63, 1.38–5.00) Received influenza vaccine last year (1.81, 1.18–2.80) High perception of SARS-CoV-2 vaccine (2.48, 1.83–3.35) Good practice (8.27, 5.35–12.77) Third trimester (1.27, 0.98–1.65) |
8 |
| Total samples | 15,444 | |||||
| NOS score | 7.17 ± 0.58 |
Abbreviation: CI = confidence interval; OR = odds ratio; NOS, Newcastle–Ottawa Quality Assessment Scale.